Rock Springs Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Rock Springs Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	59,000 +13,500	+30%	+$450K	0.1%	89
2026 Q1	$1.37M	Hold	45,500	–	–	0.08%	92
2025 Q4	$1.42M	Buy	+45,500	New	+$1.12M	0.07%	94
2016 Q3	–	Sell	-395,000	Closed	-$19.8M	–	139
2016 Q2	$19.8M	Hold	395,000	–	–	1.47%	20
2016 Q1	$21.1M	Buy	395,000 +15,700	+4%	+$921K	1.77%	14
2015 Q4	$24.9M	Buy	379,300 +54,300	+17%	+$3.36M	1.89%	14
2015 Q3	$18.4M	Buy	+325,000	New	+$21.1M	1.49%	18

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rock Springs Capital Management's TEVA Position: Q2 2026 in Review

Rock Springs Capital Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 30% in Q2 2026, buying an estimated $450K and bringing the position to 59,000 shares worth $2M. The position accounts for 0.1% of the portfolio, ranked #89.

Rock Springs Capital Management first reported a position in TEVA in Q3 2015 and has held it in 7 quarters since. The position peaked at $24.9M in Q4 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Rock Springs Capital Management held 59,000 shares of Teva Pharmaceutical Industries Limited worth $2M as of Q2 2026.
Rock Springs Capital Management bought 13,500 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $450K.
Teva Pharmaceutical Industries Limited made up 0.1% of Rock Springs Capital Management's portfolio in Q2 2026, its #89 holding.
Rock Springs Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and has held it in 7 quarters since.
Rock Springs Capital Management's Teva Pharmaceutical Industries Limited position peaked at $24.9M in Q4 2015.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.